Detection of tau phosphorylated at threonine 231 in cerebrospinal fluid of Alzheimer's disease patients

Neuroscience Letters

Volumn 287, Issue 3, 2000, Pages 187-190

  Kohnken, Russell ^a   Buerger, Katharina ^b   Zinkowski, Raymond ^a   Miller, Caudill ^c   Kerkman, Daniel ^a   Debernardis, John ^a   Shen, Jifang ^a   Möller, Hans Jürgen ^b   Davies, Peter ^d   Hampel, Harald ^b  

^a Molecular Geriatrics Corporation   (United States)

^b Department of Psychiatry   (Germany)

^c Neurology Consultants of Montgomery   (United States)

^d ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

Alzheimer's disease; Cerebrospinal fluid; Diagnosis; Phosphotau; Tau protein

Indexed keywords

MONOCLONAL ANTIBODY; TAU PROTEIN; THREONINE;

ALZHEIMER DISEASE; AUTOPSY; CEREBROSPINAL FLUID; CONTROLLED STUDY; DEMENTIA; DIAGNOSTIC ACCURACY; ENZYME LINKED IMMUNOSORBENT ASSAY; HUMAN; HUMAN TISSUE; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; SHORT SURVEY;

EID: 0034733918     PISSN: 03043940     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0304-3940(00)01178-2     Document Type: Article

References (19)

1. Arai H., Sasaki H., Trojanowski J.Q., Lee V.M., Machida N., Miura M., Clark C.M., Matsui T., Higuchi M., Morikawa Y. Cerebrospinal fluid tau levels in neurodegenerative diseases with distinct tau-related pathology. Biochem. Biophys. Res. Commun. 236:1997;262-264.
2. Biernat J., Mandelkow E.-M., Schröter C., Lichtenberg-Kraag B., Steiner B., Berling B., Meyer H., Mercken M., Vandermeeren A., Goedert M., Mandelkow E. The switch of tau protein to an Alzheimer-like state includes the phosphorylation of two serine-proline motifs up stream of the microtubule binding region. EMBO J. 11:1992;1593-1597.
3. Blennow K., Wallin A., Agren H., Spenger C., Siegfried J., Vanmechelen E. Tau protein in cerebrospinal fluid. A biochemical marker for axonal degeneration in Alzheimer disease? Mol. Chem. Neuropathol. 26:1995;231-245.
4. Folstein M.F., Folstein S., McHugh P.R. 'Mini-mental state' A practical method for grading the cognitive state of patients for the clinician. J. Psychiatr. Res. 12:1975;189-198.
5. Ghanbari H., Ghanbari K., Behesti I., Munzar M., Vasauskas A., Averback P. Biochemical assay for AD7C-NTP in urine as an Alzheimer's disease marker. J. Clin. Lab. Anal. 12:1998;285-288.
6. Hampel H., Teipel S.J., Padberg F., Haslinger A., Riemenschneider M., Schwarz M.J., Kötter H.U., Scheloske M., Buch K., Stübner S., Dukoff R., Lasser R., Müller N., Sunderland T., Rapoport S.I., Möller H-J. Discriminant power of combined cerebrospinal fluid tau protein and of the soluble interleukin-6 receptor complex in the diagnosis of Alzheimer's disease. Brain Res. 823:1999;104-112.
7. Hulstaert F., Blennow K., Ivanoiu A., Schoonderwaldt H.C., Riemenschneider M., De Deyn P.P., Bancher C., Cras P., Wiltfang J., Mehta P.D., Iqbal K., Pottel H., Vanmechelen E., Vanderstichele H. Improved discrimination of AD patients using beta-amyloid (1-42) and tau levels in CSF. Neurology. 52:1999;1555-1562.
8. Ishiguro K., Ohno H., Arai H., Yamaguchi H., Urakami K., Park J.-M., Sato K., Kohno H., Imahori K. Phosphorylated tau in human cerebrospinal fluid is a diagnostic marker for Alzheimer's disease. Neurosci. Lett. 270:1999;91-94.
9. Jicha G.A., O'Donnell A., Weaver C., Angeletti R., Davies P. Heirarchical phosphorylation of recombinant tau by the paired helical filament associated protein kinase is dependent on cAMP-dependent protein kinase. J. Neurochem. 72:1999;214-224.
10. Kanai M., Matsubara E., Isoe K., Urakami K., Nakashima K., Arai H., Sasaki H., Abe K., Iwatsubo T., Kosaka T., Watanabe M., Tomidokoro I., Shizuka M., Mizushima K., Nakamura T., Igeta Y., Ikeda Y., Amari M., Kawarabayashi T., Ishiguro K., Harigaya Y., Wakabayashi K., Okamoto K., Hirai S., Shoji M. Longitudinal study of cerebrospinal fluid levels of tau Aβ1-40, and Aβ1-42 in Alzheimer's disease: a study in Japan. Ann. Neurol. 44:1998;17-26.
11. Kang J., Lemaire H.-G., Unterbeck A., Salbaum J.M., Masters C.L., Grzeschik K.-H., Multhaup G., Beyreuther K., Muller-Hill B. The precursor of Alzheimer's disease amyloid A4 protein resembles a cell-surface receptor. Nature. 325:1987;733-736.
12. Kennard M.L., Feldman H., Yamada T., Jefferies W.A. Serum levels of the iron binding protein p97 are elevated in Alzheimer's disease. Nat. Med. 2:1996;1230-1235.
13. Lewis D., Campbell M., Terry R., Morrison J. Laminar and regional distributions of neurfibrillary tangles and neuritic plaques in Alzheimer's disease: a quantitative study of visual and auditory cortices. J. Neurosci. 7:1987;1799-1808.
14. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA work group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
15. Parker W.D. Jr., Mahr N.J., Filley C.M., Parks J.K., Hughes D., Young D.A., Cullum C.M. Reduced platelet cytochrome c oxidase activity in Alzheimer's disease. Neurology. 44:1994;1086-1090.
16. Tierney M.C., Fisher R.H., Lewis A.K., Zorzitto M.L., Snow W.G., Reid D.W., Nieuwstraten P. The NINCDS-ADRDA work group criteria for the clinical diagnosis of probable Alzheimer's disease: a clinicopathologic study of 57 cases. Neurology. 38:1988;359-364.
17. Vandermeeren M., Mercken M., Vanmechelen E., Six J., Van de Voorde A., Martin J.-J., Cras P. Detection of tau proteins in normal and Alzheimer's disease cerebrospinal fluid with a sensitive sandwich enzyme-linked immunosorbent assay. J. Neurochem. 61:1993;1828-1834.
18. Vigo-Pelfrey C., Seubert P., Barbour R., Blomquist C., Lee M., Lee D., Coria F., Chang L., Miller B., Lieberburg I., Schenk D. Elevation of microtubule-associated protein tau in the cerebrospinal fluid of Alzheimer's patients. Neurology. 45:1995;788-793.
19. Wolozin B., Davies P. Alzheimer-related neuronal protein A68: specificity and distribution. Ann. Neurol. 22:1987;521-526.